
Zypred0.5%+0.3%
Aristopharma Ltd.
Loteprednol Etabonate + Gatifloxacin ophthalmic suspension is a corticosteroid-antibiotic combination indicated for: Established/approved use: Treatment of steroid-responsive inflammatory ocular…
Loteprednol Etabonate + Gatifloxacin ophthalmic suspension is a corticosteroid-antibiotic combination indicated for:
Loteprednol Etabonate + Gatifloxacin is not indicated for the initial treatment of bacterial conjunctivitis alone (without a clear steroid-responsive inflammatory component), nor as an antibiotic used without concurrent need for the corticosteroid effect. It must not be used to treat infections without adequate concurrent antimicrobial therapy where the infecting organism is not susceptible.
| Indication | Adult Dosage |
|---|---|
| Post-operative inflammation with risk/presence of bacterial infection | Instill 1–2 drops into the conjunctival sac of the affected eye(s) four times daily. During the first 24–48 hours in more severe cases, dosing frequency may be increased to every 1–2 hours as directed by the ophthalmologist, then tapered as inflammation subsides. |
| Blepharoconjunctivitis/blepharokeratoconjunctivitis with bacterial component | Instill 1–2 drops into the affected eye(s) 2–4 times daily, or as prescribed, for the duration directed by the physician. |
Administration technique: Shake well before use. Tilt the head back, gently pull down the lower eyelid to form a pouch, and instill the prescribed number of drops without letting the dropper tip touch the eye, eyelid, or any surface (to avoid contamination). Close the eye gently for 1–2 minutes after instillation and apply light pressure over the tear duct (punctal occlusion) to minimize systemic absorption. If more than one topical ophthalmic product is used, allow at least 5–10 minutes between applications.
Duration: Treatment courses are typically short (commonly up to 1–2 weeks); prolonged use beyond what is prescribed should be avoided due to corticosteroid-related ocular risks. Complete the full course of Loteprednol Etabonate + Gatifloxacin exactly as prescribed by the physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
Pediatric and renal/hepatic dosing: see Use in Special Populations.
Reported adverse effects with Loteprednol Etabonate + Gatifloxacin include:
Patients should report any worsening eye pain, vision changes, persistent redness, or signs of new infection promptly.
Loteprednol Etabonate + Gatifloxacin is contraindicated in:
These contraindications exist because the corticosteroid component may suppress the host response and mask or worsen untreated infections of these types, or because of true hypersensitivity risk.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.